Literature DB >> 19053069

Development of new substrates for high-sensitive genotyping of minority mutated alleles.

Silvia Galbiati1, Francesco Damin, Gabriele Di Carlo, Maurizio Ferrari, Laura Cremonesi, Marcella Chiari.   

Abstract

An unsurpassed level of sensitivity was reached in the detection of minority mutated alleles. A low-density microarray was printed on a substrate specifically designed to provide an interference effect which amplifies the collection of the light emitted on the support and reinforces the intensity of excitation light. Optimal performance of the array was obtained by maximizing the probe density and the binding efficiency to the target through a polymeric coating made by the adsorption of a copolymer of N,N-dimethylacrylamide (97% of moles), N,N-acryloyloxysuccinimide (2%) and 3-(trimethoxysilyl)propyl methacrylate (1%) synthesized by free radical copolymerization. The new substrate was used in the identification of fetal mutations in the maternal plasma DNA. Amino-modified amplicons from genomic DNA corresponding to the locus of eight beta-thalassemia mutations were immobilized and interrogated with dual-color oligonucleotide targets. Compared with the conventional glass substrates, the new substrate showed a great enhancement of fluorescence signals thanks to the combination of the optics with the highly efficient polymeric coating, allowing specific detection of all mutations. The high sensitivity and selectivity obtained made it possible to develop assays for the identification of paternally inherited mutations on fetal DNA in the maternal plasma in couples at risk for beta-thalassemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053069     DOI: 10.1002/elps.200800242

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  1 in total

1.  A new microarray substrate for ultra-sensitive genotyping of KRAS and BRAF gene variants in colorectal cancer.

Authors:  Silvia Galbiati; Francesco Damin; Pamela Pinzani; Irene Mancini; Serena Vinci; Marcella Chiari; Claudio Orlando; Laura Cremonesi; Maurizio Ferrari
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.